Atrium Therapeutics, Inc. (RNA)

Atrium Therapeutics Revenue

In the year 2025, Atrium Therapeutics had annual revenue of $18.76M with 72.11% growth. Atrium Therapeutics had revenue of $860.00K in the quarter ending December 31, 2025, a decrease of -71.07%.

• Revenue (ttm): $18.76M
• Revenue Growth: +72.11%
• P/S Ratio: 5.36
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 196.54M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	18.76M	7.86M	72.11%
Dec 31, 2024	10.90M	1.34M	13.99%
Dec 31, 2023	9.56M	336.00K	3.64%
Dec 31, 2022	9.22M	-102.00K	-1.09%
Dec 31, 2021	9.33M	2.54M	37.41%
Dec 31, 2020	6.79M	4.47M	192.67%
Dec 31, 2019	2.32M	1.94M	511.87%
Dec 31, 2018	379.00K	-	-

Data Source: Fiscal.ai Last updated: Mar 31, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 25, 2026

Data Sources Report a data error